Atwood & Palmer’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
63,924
+228
| +0.4% | +$65.5K | 1.15% | 40 |
|
|
2025
Q1 | $19.6M | Sell |
63,696
-879
| -1% | -$271K | 1.36% | 34 |
|
|
2024
Q4 | $22.8M | Buy |
64,575
+519
| +0.8% | +$183K | 1.56% | 29 |
|
|
2024
Q3 | $23M | Buy |
64,056
+294
| +0.5% | +$105K | 1.56% | 28 |
|
|
2024
Q2 | $20.3M | Buy |
63,762
+165
| +0.3% | +$52.6K | 1.54% | 28 |
|
|
2024
Q1 | $14.6M | Buy |
63,597
+3,725
| +6% | +$856K | 1.11% | 41 |
|
|
2023
Q4 | $13.2M | Buy |
59,872
+303
| +0.5% | +$66.6K | 1.06% | 42 |
|
|
2023
Q3 | $13.5M | Buy |
59,569
+580
| +1% | +$131K | 1.18% | 42 |
|
|
2023
Q2 | $13M | Buy |
58,989
+430
| +0.7% | +$94.9K | 1.16% | 37 |
|
|
2023
Q1 | $13.1M | Buy |
58,559
+2,372
| +4% | +$531K | 1.23% | 34 |
|
|
2022
Q4 | $15.6M | Buy |
56,187
+720
| +1% | +$200K | 1.41% | 27 |
|
|
2022
Q3 | $11.6M | Buy |
55,467
+679
| +1% | +$142K | 1.15% | 35 |
|
|
2022
Q2 | $12.9M | Buy |
+54,788
| New | +$12.9M | 1.26% | 35 |
|